CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Low dose radiation therapyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.06

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials


1 Low Dose Radiation Therapy for Covid-19 Pneumonia: A Pilot Study

Radiotherapy in low doses (30 to 100 cGy) was a popular treatment of viral pneumonias until 1940s. Low dose radiation therapy (LDRT) could possibly reduce the inflammation and prevent the cytokine storm thus mitigating the severity of pneumonitis. This is a single arm study designed to assess the feasibility and clinical efficacy of low dose radiation therapy (70 cGy in single fraction) in the patients with COVID-19 pneumonia. A total of 10 eligible patients (as per inclusion criteria) will be recruited and response will be assessed based on the symptomatic improvement or deterioration by using the National Early Warning Score (NEWS). The NEWS score will be recorded on baseline and then on Day 3, Day 7 and Day 14.

NCT04394793 COVID-19 Pneumonia Radiation: Low dose radiation therapy
MeSH:Pneumonia
HPO:Pneumonia

Primary Outcomes

Description: NEWS score

Measure: Symptomatic improvement by National Early warning score (NEWS)

Time: Day 3

Description: NEWS score

Measure: Symptomatic improvement by National Early warning score (NEWS)

Time: Day 7

Description: NEWS score

Measure: Symptomatic improvement by National Early warning score (NEWS)

Time: Day 14

Description: Days

Measure: Length of hospital stay

Time: 30 days or date of death whichever is earlier

Description: Number of patients

Measure: Number of ICU admissions or deaths

Time: 30 days


Related HPO nodes (Using clinical trials)